1. Home
  2. SCYX vs BOTJ Comparison

SCYX vs BOTJ Comparison

Compare SCYX & BOTJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • BOTJ
  • Stock Information
  • Founded
  • SCYX 1999
  • BOTJ 1998
  • Country
  • SCYX United States
  • BOTJ United States
  • Employees
  • SCYX N/A
  • BOTJ N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • BOTJ Major Banks
  • Sector
  • SCYX Health Care
  • BOTJ Finance
  • Exchange
  • SCYX Nasdaq
  • BOTJ Nasdaq
  • Market Cap
  • SCYX 50.3M
  • BOTJ 60.2M
  • IPO Year
  • SCYX 2014
  • BOTJ N/A
  • Fundamental
  • Price
  • SCYX $1.18
  • BOTJ $14.60
  • Analyst Decision
  • SCYX Buy
  • BOTJ
  • Analyst Count
  • SCYX 1
  • BOTJ 0
  • Target Price
  • SCYX N/A
  • BOTJ N/A
  • AVG Volume (30 Days)
  • SCYX 165.3K
  • BOTJ 6.4K
  • Earning Date
  • SCYX 11-06-2024
  • BOTJ 10-25-2024
  • Dividend Yield
  • SCYX N/A
  • BOTJ 2.80%
  • EPS Growth
  • SCYX N/A
  • BOTJ N/A
  • EPS
  • SCYX N/A
  • BOTJ 1.86
  • Revenue
  • SCYX $8,566,000.00
  • BOTJ $43,923,000.00
  • Revenue This Year
  • SCYX N/A
  • BOTJ N/A
  • Revenue Next Year
  • SCYX $145.59
  • BOTJ N/A
  • P/E Ratio
  • SCYX N/A
  • BOTJ $7.83
  • Revenue Growth
  • SCYX N/A
  • BOTJ 1.36
  • 52 Week Low
  • SCYX $1.15
  • BOTJ $9.65
  • 52 Week High
  • SCYX $3.07
  • BOTJ $15.75
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 28.95
  • BOTJ 68.12
  • Support Level
  • SCYX $1.25
  • BOTJ $14.01
  • Resistance Level
  • SCYX $1.37
  • BOTJ $14.58
  • Average True Range (ATR)
  • SCYX 0.06
  • BOTJ 0.39
  • MACD
  • SCYX -0.01
  • BOTJ 0.11
  • Stochastic Oscillator
  • SCYX 9.26
  • BOTJ 100.00

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About BOTJ Bank of the James Financial Group Inc.

Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments, community banking; mortgage banking, and investment advisory services.

Share on Social Networks: